Medical News |
- Insulin more effective add-on than sitagliptin in glucose control
- Anti-TNFs increase risk for herpes zoster infections in IRD patients
- Psoriasis TNF-α therapeutic effects mediated by MSC antioxidant reduction
- Tests could avoid unnecessary DVT investigations in elderly, frail
| Insulin more effective add-on than sitagliptin in glucose control Posted: 14 Jun 2012 05:00 PM PDT Insulin seems to be a more effective add-on regimen than sitagliptin in patients with diabetes inadequately controlled by metformin monotherapy, show study findings. |
| Anti-TNFs increase risk for herpes zoster infections in IRD patients Posted: 14 Jun 2012 05:00 PM PDT Patients with inflammatory rheumatic diseases who are treated with anti-tumor necrosis factor medications are significantly more likely to experience herpes zoster infections than those treated with traditional disease-modifying anti-rheumatic drugs, study results show. |
| Psoriasis TNF-α therapeutic effects mediated by MSC antioxidant reduction Posted: 14 Jun 2012 05:00 PM PDT The therapeutic effects of tumor necrosis factor-α inhibitors in psoriasis occur through a reduction in the antioxidant response of mesenchymal stem cells, suggest study findings. |
| Tests could avoid unnecessary DVT investigations in elderly, frail Posted: 13 Jun 2012 05:00 PM PDT Two age-adapted D-dimer tests can be safely used to exclude deep-vein thrombosis in elderly patients in primary care, suggests research published in the BMJ. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment